Pfizer and BioNTech seek FDA authorization for updated Covid-19 booster – CNN

This updated formulation will combine the original vaccine with one that targets Omicron sublineages BA.4 and BA.5, and would be administered as a 30 microgram dose. The companies say they are following “guidance from the FDA” and are including clinical data of their bivalent BA.1 vaccine and pre-clinical and manufacturing Read more…